Abiopharma

New Form SCHEDULE 13G - DBV Technologies S.A. Filed: 2025-08-12 AccNo: 0000902664-25-003512 Size: 17 KB

New Form SCHEDULE 13G/A - Janux Therapeutics, Inc. Filed: 2025-08-12 AccNo: 0000902664-25-003510 Size: 12 KB

New Form SCHEDULE 13G/A - SOLENO THERAPEUTICS INC Filed: 2025-08-12 AccNo: 0000902664-25-003509 Size: 12 KB

New Form SCHEDULE 13G/A - IMMUNIC, INC. Filed: 2025-08-12 AccNo: 0000902664-25-003508 Size: 13 KB

New Form SCHEDULE 13G/A - Wave Life Sciences Ltd. Filed: 2025-08-12 AccNo: 0000902664-25-003507 Size: 12 KB

New Form SCHEDULE 13G/A - Cabaletta Bio, Inc. Filed: 2025-08-12 AccNo: 0000902664-25-003505 Size: 13 KB

New Form SCHEDULE 13G/A - ProQR Therapeutics N.V. Filed: 2025-08-12 AccNo: 0000902664-25-003504 Size: 12 KB

New Form SCHEDULE 13G/A - Ensysce Biosciences, Inc. Filed: 2025-08-12 AccNo: 0000902664-25-003503 Size: 12 KB

New Form SCHEDULE 13G/A - Cidara Therapeutics, Inc. Filed: 2025-08-12 AccNo: 0000902664-25-003502 Size: 13 KB

New Form SCHEDULE 13G/A - Inozyme Pharma, Inc. Filed: 2025-08-12 AccNo: 0000902664-25-003501 Size: 11 KB

New Form SCHEDULE 13G/A - Praxis Precision Medicines, Inc. Filed: 2025-08-12 AccNo: 0000902664-25-003499 Size: 12 KB

New Form SCHEDULE 13G/A - Centessa Pharmaceuticals plc Filed: 2025-08-12 AccNo: 0000902664-25-003498 Size: 13 KB

New Form SCHEDULE 13G/A - Fulcrum Therapeutics, Inc. Filed: 2025-08-12 AccNo: 0000902664-25-003497 Size: 12 KB

HealthEquity Community Foundation Expands National Impact with $50,000 in Grants

Jaguar Health to Hold Investor Webcast Thursday, August 14 at 8:30 AM Eastern Regarding Q2 2025 Financials & Corporate Updates